Juan Du

Juan Du


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MTMiao-Miao Tian
Miao-Miao Tian
YLYu-Xiang Li
Yu-Xiang Li
SLShan Liu
Shan Liu
CZChun-Hao Zhu
Chun-Hao Zhu
XLXiao-Bing Lan
Xiao-Bing Lan
NLNing Liu
Ning Liu
Neuropathic pain is a refractory disease that occurs across the world and pharmacotherapy has limited efficacy and/or safety. This disease imposes a significant burden on both the somatic and mental health of patients; indeed, some patients have referred to neuropathic pain as being ‘worse than death’. The pharmacological agents that are used to treat neuropathic pain at present can produce mild effects in certain patients, and induce many adverse reactions, such as sedation, dizziness, vomiting, and peripheral oedema. Therefore, there is an urgent need to discover novel drugs that are safer and more effective. Natural compounds from medical plants have become potential sources of analgesics, and evidence has shown that glycosides alleviated neuropathic pain via regulating oxidative stress, transcriptional regulation, ion channels, membrane receptors and so on. In this review, we summarize the epidemiology of neuropathic pain and the existing therapeutic drugs used for disease prevention and treatment. We also demonstrate how glycosides exhibit an antinociceptive effect on neuropathic pain in laboratory research and describe the antinociceptive mechanisms involved to facilitate the discovery of new drugs to improve the quality of life of patients experiencing neuropathic pain.

26 August 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
QYQing You
Qing You
XLXiao-Bing Lan
Xiao-Bing Lan
NLNing Liu
Ning Liu
JDJuan Du
Juan Du
LMLin Ma
Lin Ma
JYJianqiang Yu
Jianqiang Yu

11 June 2025 in Neoplasia
Verified
Journal Article
Open access
YLYiming Liu
Yiming Liu
XJXingyu Jiang
Xingyu Jiang
DJDongquan Jing
Dongquan Jing
YLYanting Lin
Yanting Lin
RGRui Gao
Rui Gao
XGXinghua Gao
Xinghua Gao
Long-chain acyl-CoA synthetase 4 (ACSL4), a crucial modulator of ferroptosis, is associated with tumor progression, though its impact on colorectal cancer (CRC) immune dynamics is not fully understood. ACSL4 expression was analyzed in CRC tissues and correlated with patient prognosis. Effects of ACSL4 were evaluated in CRC cells in vitro and in subcutaneous and orthotopic CRC models. Flow cytometry and immunofluorescence were used to evaluate immune cell infiltration. RNA sequencing and RT-PCR were employed to identify ACSL4-regulated signaling pathways. The effect of ACSL4 silencing on PD-L1 blockade efficacy was also examined. ACSL4 levels were markedly increased in CRC and linked to unfavorable patient outcomes. While ACSL4 knockdown had no direct effect on CRC cell proliferation, it significantly suppressed tumor growth in immunocompetent mice. ACSL4 depletion enhanced CD3⁺ and CD8⁺ T cell infiltration and upregulated chemokines (CXCL10, CXCL11) and antigen presentation genes (H2k1, TAP1, TAPBP). Transcriptomic analysis highlighted activation of the RIG-I-MAVS-driven type I interferon pathway. Co-culture assays demonstrated that ACSL4 knockdown promoted CD8⁺ T cell activation, and ACSL4-deficient tumors exhibited enhanced responsiveness to PD-L1 blockade. ACSL4 suppresses anti-tumor immunity in CRC by modulating the RIG-I-MAVS-IFN pathway, highlighting ACSL4 as a promising target for CRC immunotherapy.

27 September 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YCYan-Nan Chi
Yan-Nan Chi
JYJia-Mei Yang
Jia-Mei Yang
NLNing Liu
Ning Liu
YCYan-Hong Cui
Yan-Hong Cui
LMLin Ma
Lin Ma
JDJuan Du
Juan Du
Chemotherapy is one of the causes of ovarian injury and infertility. Although assisted reproductive technology helps young female patients with cancer become pregnant, preventing chemotherapy-induced ovarian injury will often possess even more significant benefits. We aimed at demonstrating the hazardous effects and mechanisms of ovarian injury by chemotherapeutic agents, as well as demonstrating agents that protect the ovary from chemotherapy-induced injury. Chemotherapeutic agents cause death or accelerate activation of follicles and damage to the blood vessels in the ovary, resulting in inflammation. These often require drug development to protect the ovaries from injury. Our findings provide a basis for the development of drugs to protect the ovaries from injury. Although there are many preclinical studies on potential protective drugs, there is still an urgent need for a large number of clinical experiments to verify their potential use.

11 March 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SLShan Liu
Shan Liu
XLXiao-Bing Lan
Xiao-Bing Lan
MTMiao-Miao Tian
Miao-Miao Tian
CZChun-Hao Zhu
Chun-Hao Zhu
LMLin Ma
Lin Ma
NLNing Liu
Ning Liu